Yinghong Li
Orcid: 0000-0003-3629-519XAffiliations:
- Zhejiang University, College of Pharmaceutical Sciences, Hangzhou, China
- Chongqing University, School of Pharmaceutical Sciences and Collaborative Innovation Center for Brain Science, Innovative Drug Research and Bioinformatics Group, Chongqing, China
- National University of Singapore, Department of Pharmacy and Center for Computational Science and Engineering, Bioinformatics and Drug Design Group, Singapore
According to our database1,
Yinghong Li
authored at least 8 papers
between 2014 and 2021.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on publons.com
-
on orcid.org
On csauthors.net:
Bibliography
2021
Briefings Bioinform., 2021
2020
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics.
Nucleic Acids Res., 2020
ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies.
Briefings Bioinform., 2020
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
Briefings Bioinform., 2020
2018
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.
Nucleic Acids Res., 2018
2017
Nucleic Acids Res., 2017
2016
Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.
Nucleic Acids Res., 2016
2014
Nucleic Acids Res., 2014